http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190020104-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eb6dbca25e5f9459a6c5f592728c787
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2017-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9faaad983430d24c7a41dfa95da81982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aba327b5a36b741b0018b2d21736a4fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90823d6c2c1fe3a9712e546e81f048e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6231253f5ac2bbd3c66a7b1449790385
publicationDate 2019-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20190020104-A
titleOfInvention N- (substituted-phenyl) -sulfonamide derivatives as kinase inhibitors
abstract The present invention relates to N- (substituted-phenyl) -sulfonamide compounds which are very useful as inhibitors of protein kinases (e. G., PERK kinase) and are useful for the treatment of cell proliferative disorders such as cancer, Can be used for the treatment of diseases associated with the activated unfolded protein response pathway. The present invention also provides methods for the manufacture of these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases using pharmaceutical compositions comprising these compounds.
priorityDate 2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015136463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0017202-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465033539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465398822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467395210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429355474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465986597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465655829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464967050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465650390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163864232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465079543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132256680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465268765
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465718588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467536814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138743123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429355450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465592770

Total number of triples: 49.